RSNN Annual workshop 2024
Artificial Intelligence in Regulatory Innovation
Tuesday 11 June 2024, 13:00-17:15 with drinks and optional dinner afterwards
in person only at Villa Jongerius, Utrecht
Background
Artificial intelligence (AI) is emerging as a transformative tool in regulatory science, revolutionizing traditional approaches to ensuring the safety, efficacy, and quality of products and services. As also stated in the EMA draft reflection paper on the use of AI in the medicinal product lifecycle, the quickly developing field of AI shows great promise for enhancing all phases of the medicinal product lifecycle, while also introducing new risks that need to be mitigated to ensure the safety of patients and integrity of clinical study results.
In this RSNN workshop we want to share knowledge and experiences of the use of AI in regulatory innovation from the perspective of regulators, patients, industries, academia, and other stakeholders. Discussions with the audience, representing various backgrounds, are a critical element in this respect.
Confirmed speakers:
Program
The preliminary workshop program is available here.
Organizing committee
- Marieke De Bruin (UU, co-chair RSNN)
- Sophie Huiskes (Lygature, RSNN)
- Florence van Hunsel (Lareb)
- Doan Nguyen (Johnson & Johnson)
- Mark Pieters (Lygature, RSNN)
- Stefan Verweij (CBG-MEB)
About the RSNN
The Regulatory Science Network Netherlands (RSNN) is a network of regulatory science experts from industry, academia, governmental bodies and the broader regulatory science field. Our mission is to advance an efficient and effective regulatory system for drug development, marketing authorization and access, and appropriate use of medicines by pooling expertise of all stakeholders, sharing and disseminating knowledge and setting the agenda for further research.
Contact
If you have any questions, please contact: info@rsnn.nl